Related references
Note: Only part of the references are listed.Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
Hui Ma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2009)
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
Rami Moucari et al.
HEPATOLOGY (2009)
Hepatitis B Surface Antigen Quantification as a Current-Day Paradox: Obtaining the Gold in the Face of Diminishing Returns
Robert P. Perrillo
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
Rami Moucari et al.
JOURNAL OF HEPATOLOGY (2009)
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
Erik H. C. J. Buster et al.
GASTROENTEROLOGY (2008)
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
Michael W. Fried et al.
HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
F. Bonino et al.
GUT (2007)
Therapy of hepatitis B - Viral suppression or eradication?
RP Perrillo
HEPATOLOGY (2006)
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy
P Lampertico et al.
HEPATOLOGY (2003)
Share Paper
